Microwave Ablation (MWA) technology
搜索文档
Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh
Prnewswire· 2025-10-23 20:30
About Baird Medical Baird Medical is a forward-thinking medical device company specializing in minimally invasive diagnostics and treatment. It is dedicated to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments. Our mission is to enhance patient outcomes through precision technology and advanced diagnostic solutions. The company will foster strategic collaborations with leading academic institutions. Our vision extends beyond surgical assistance, ...
Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia
Prnewswire· 2025-10-21 20:30
Accessibility StatementSkip Navigation NEW YORK, Oct. 21, 2025 /PRNewswire/ --Â Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the Thyroid Microwave Ablation Workshop held at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia. Training in Malaysia The immersive two-day workshop, held from October 1–2, 2025, brought together leading surgeons and end ...
Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop
Prnewswire· 2025-10-20 20:30
Accessibility StatementSkip Navigation NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. The prestigious academic event was hosted by the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025. The 3rd International Workshop on Thermal Ablat ...
Baird Medical Advances Microwave Ablation Training at Leading U.S. Thyroid Centers
Prnewswire· 2025-10-01 20:39
公司近期活动 - 公司在杜兰大学和哥伦比亚大学等美国顶尖学术医疗中心主办了一系列医师培训项目 [1] - 这些培训是密集的实践操作课程,旨在提升医师使用微波消融技术治疗甲状腺结节的临床熟练度 [1] - 5月在杜兰大学的培训由外科教授Emad Kandil博士主导,通过5个真实病例为来自乔治华盛顿大学、UT Health Houston和德州理工大学健康科学中心的专家提供了沉浸式训练 [2] - 5月和8月在哥伦比亚大学由介入内分泌项目主任Jennifer Kuo博士主导的专门课程,培训了来自UCSF Health和Dignity Health的医师 [2] 公司战略与承诺 - 公司致力于培养临床卓越性,确保其微波消融技术被安全、有效地采用 [2] - 公司使命不仅限于开发创新技术,还包括确保临床医生经过专业培训以提供最佳患者 outcomes [3] - 公司与世界级机构的合作是致力于在该领域设定最高护理标准的基础 [3] - 公司计划扩大其教育计划并与关键意见领袖合作,以进一步确立微波消融作为甲状腺疾病患者的主要治疗选择 [3] 公司业务概览 - 公司是一家专注于微创诊断和治疗的医疗器械公司 [4] - 公司致力于手术机器人系统和创新微创手术器械的研发 [4] - 公司是甲状腺微波消融设备和耗材的中国市场领导者 [4] - 公司的微创治疗产品正逐步扩大其在全球超过20个国家的商业存在 [4] 公司市场地位与客户 - 公司是美国FDA 510(k)认证的医疗器械公司 [4] - 公司的解决方案已在美国超过30家著名医院和诊所使用,包括约翰霍普金斯医院、杜兰医学中心、威尔康奈尔医学中心和哥伦比亚大学医学中心 [4]